Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.55320763 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.55320763 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.52784372 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.52784372 |
5 | cysteine metabolic process (GO:0006534) | 6.13030854 |
6 | glyoxylate metabolic process (GO:0046487) | 5.94221723 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.89487291 |
8 | COPI coating of Golgi vesicle (GO:0048205) | 5.45617736 |
9 | Golgi transport vesicle coating (GO:0048200) | 5.45617736 |
10 | lysine catabolic process (GO:0006554) | 5.45280628 |
11 | lysine metabolic process (GO:0006553) | 5.45280628 |
12 | drug transmembrane transport (GO:0006855) | 5.39398960 |
13 | indole-containing compound catabolic process (GO:0042436) | 5.31324092 |
14 | indolalkylamine catabolic process (GO:0046218) | 5.31324092 |
15 | tryptophan catabolic process (GO:0006569) | 5.31324092 |
16 | urate metabolic process (GO:0046415) | 5.10934525 |
17 | sulfur amino acid catabolic process (GO:0000098) | 5.03710212 |
18 | protein maturation by protein folding (GO:0022417) | 5.02478898 |
19 | tryptophan metabolic process (GO:0006568) | 4.97791350 |
20 | kynurenine metabolic process (GO:0070189) | 4.79977168 |
21 | drug transport (GO:0015893) | 4.72103236 |
22 | serine family amino acid catabolic process (GO:0009071) | 4.65354951 |
23 | aldehyde catabolic process (GO:0046185) | 4.60339577 |
24 | serine family amino acid metabolic process (GO:0009069) | 4.58790694 |
25 | serine family amino acid biosynthetic process (GO:0009070) | 4.57848022 |
26 | bile acid biosynthetic process (GO:0006699) | 4.53099678 |
27 | amino-acid betaine metabolic process (GO:0006577) | 4.52356000 |
28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.51464678 |
29 | homocysteine metabolic process (GO:0050667) | 4.50227383 |
30 | aromatic amino acid family metabolic process (GO:0009072) | 4.42204059 |
31 | aspartate family amino acid catabolic process (GO:0009068) | 4.30712084 |
32 | heme transport (GO:0015886) | 4.28037339 |
33 | drug catabolic process (GO:0042737) | 4.27123177 |
34 | short-chain fatty acid metabolic process (GO:0046459) | 4.26145968 |
35 | cellular modified amino acid catabolic process (GO:0042219) | 4.19718765 |
36 | alpha-amino acid catabolic process (GO:1901606) | 4.13537380 |
37 | acetyl-CoA metabolic process (GO:0006084) | 4.06886313 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 4.03436135 |
39 | cellular amino acid catabolic process (GO:0009063) | 4.03165989 |
40 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.00509195 |
41 | protein retention in ER lumen (GO:0006621) | 4.00242583 |
42 | urea cycle (GO:0000050) | 3.98090783 |
43 | urea metabolic process (GO:0019627) | 3.98090783 |
44 | glutamate metabolic process (GO:0006536) | 3.97184936 |
45 | bile acid metabolic process (GO:0008206) | 3.96933418 |
46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.96775800 |
47 | cellular ketone body metabolic process (GO:0046950) | 3.95317186 |
48 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.95205095 |
49 | proline biosynthetic process (GO:0006561) | 3.93386794 |
50 | response to mercury ion (GO:0046689) | 3.90545602 |
51 | nitrogen cycle metabolic process (GO:0071941) | 3.86685902 |
52 | exogenous drug catabolic process (GO:0042738) | 3.84367325 |
53 | ethanol oxidation (GO:0006069) | 3.80213675 |
54 | amine catabolic process (GO:0009310) | 3.78455159 |
55 | cellular biogenic amine catabolic process (GO:0042402) | 3.78455159 |
56 | mitotic nuclear envelope reassembly (GO:0007084) | 3.77946112 |
57 | nuclear envelope reassembly (GO:0031468) | 3.77946112 |
58 | coenzyme catabolic process (GO:0009109) | 3.75040363 |
59 | branched-chain amino acid catabolic process (GO:0009083) | 3.74491821 |
60 | fatty acid beta-oxidation (GO:0006635) | 3.74005968 |
61 | alpha-linolenic acid metabolic process (GO:0036109) | 3.72428598 |
62 | glycine metabolic process (GO:0006544) | 3.71964408 |
63 | indolalkylamine metabolic process (GO:0006586) | 3.70922684 |
64 | regulation of translational fidelity (GO:0006450) | 3.70642654 |
65 | fructose metabolic process (GO:0006000) | 3.69556518 |
66 | branched-chain amino acid metabolic process (GO:0009081) | 3.69460197 |
67 | establishment of integrated proviral latency (GO:0075713) | 3.68356518 |
68 | cellular glucuronidation (GO:0052695) | 3.67217419 |
69 | cofactor catabolic process (GO:0051187) | 3.66514511 |
70 | carnitine metabolic process (GO:0009437) | 3.65708676 |
71 | organic acid catabolic process (GO:0016054) | 3.64079674 |
72 | carboxylic acid catabolic process (GO:0046395) | 3.64079674 |
73 | proline metabolic process (GO:0006560) | 3.62764797 |
74 | regulation of mitochondrial translation (GO:0070129) | 3.62142187 |
75 | uronic acid metabolic process (GO:0006063) | 3.61028237 |
76 | glucuronate metabolic process (GO:0019585) | 3.61028237 |
77 | fatty acid oxidation (GO:0019395) | 3.59537491 |
78 | tyrosine metabolic process (GO:0006570) | 3.59318706 |
79 | negative regulation of fibrinolysis (GO:0051918) | 3.59189481 |
80 | * glutathione derivative metabolic process (GO:1901685) | 3.58967113 |
81 | * glutathione derivative biosynthetic process (GO:1901687) | 3.58967113 |
82 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.58368836 |
83 | L-ascorbic acid metabolic process (GO:0019852) | 3.55185887 |
84 | lipid oxidation (GO:0034440) | 3.54964520 |
85 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.54697988 |
86 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.49015166 |
87 | protein carboxylation (GO:0018214) | 3.49015166 |
88 | high-density lipoprotein particle remodeling (GO:0034375) | 3.48748714 |
89 | organic cation transport (GO:0015695) | 3.48452612 |
90 | DNA unwinding involved in DNA replication (GO:0006268) | 3.47100406 |
91 | * nonribosomal peptide biosynthetic process (GO:0019184) | 3.46186199 |
92 | DNA strand elongation (GO:0022616) | 3.44829808 |
93 | response to nitrosative stress (GO:0051409) | 3.44583659 |
94 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.44153585 |
95 | valine metabolic process (GO:0006573) | 3.42716803 |
96 | fatty acid catabolic process (GO:0009062) | 3.42621441 |
97 | formation of translation preinitiation complex (GO:0001731) | 3.42012286 |
98 | plasma lipoprotein particle clearance (GO:0034381) | 3.41962790 |
99 | flavonoid metabolic process (GO:0009812) | 3.41130569 |
100 | benzene-containing compound metabolic process (GO:0042537) | 3.41052293 |
101 | L-serine metabolic process (GO:0006563) | 3.40411045 |
102 | ketone body metabolic process (GO:1902224) | 3.39737272 |
103 | regulation of cholesterol esterification (GO:0010872) | 3.38146595 |
104 | drug metabolic process (GO:0017144) | 3.38041174 |
105 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.36959506 |
106 | bile acid and bile salt transport (GO:0015721) | 3.36011365 |
107 | phosphate ion transmembrane transport (GO:0035435) | 3.35582027 |
108 | phosphate ion transport (GO:0006817) | 3.34665313 |
109 | negative regulation of sterol transport (GO:0032372) | 3.34279106 |
110 | negative regulation of cholesterol transport (GO:0032375) | 3.34279106 |
111 | monocarboxylic acid catabolic process (GO:0072329) | 3.33481663 |
112 | sulfur amino acid metabolic process (GO:0000096) | 3.32995912 |
113 | pentose-phosphate shunt (GO:0006098) | 3.32991775 |
114 | acylglycerol homeostasis (GO:0055090) | 3.32775783 |
115 | triglyceride homeostasis (GO:0070328) | 3.32775783 |
116 | * glutathione metabolic process (GO:0006749) | 3.31879973 |
117 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.30633124 |
118 | * glutathione biosynthetic process (GO:0006750) | 3.29833615 |
119 | response to phenylpropanoid (GO:0080184) | 3.28930880 |
120 | 2-oxoglutarate metabolic process (GO:0006103) | 3.28499815 |
121 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.28455647 |
122 | mitotic chromosome condensation (GO:0007076) | 3.27306562 |
123 | tRNA aminoacylation for protein translation (GO:0006418) | 3.27083773 |
124 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.26704236 |
125 | establishment of viral latency (GO:0019043) | 3.25012917 |
126 | GDP-mannose metabolic process (GO:0019673) | 3.24149628 |
127 | NADPH regeneration (GO:0006740) | 3.23703391 |
128 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.19308666 |
129 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.17309158 |
130 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.16012709 |
131 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.14407832 |
132 | negative regulation of ligase activity (GO:0051352) | 3.14407832 |
133 | amino acid activation (GO:0043038) | 3.13337244 |
134 | tRNA aminoacylation (GO:0043039) | 3.13337244 |
135 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.11212418 |
136 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.03751394 |
137 | pentose metabolic process (GO:0019321) | 2.94950267 |
138 | tricarboxylic acid cycle (GO:0006099) | 2.94097358 |
139 | glucose catabolic process (GO:0006007) | 2.93481812 |
140 | proteasome assembly (GO:0043248) | 2.92483499 |
141 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.92274207 |
142 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.91494297 |
143 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.91073498 |
144 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.91073498 |
145 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.87789762 |
146 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.87789762 |
147 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.86571799 |
148 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.86571799 |
149 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.86571799 |
150 | ribosomal small subunit assembly (GO:0000028) | 2.80917809 |
151 | positive regulation of ligase activity (GO:0051351) | 2.80301718 |
152 | ribosome assembly (GO:0042255) | 2.79094287 |
153 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.78698702 |
154 | NADH metabolic process (GO:0006734) | 2.75575194 |
155 | ribosome biogenesis (GO:0042254) | 2.75082812 |
156 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.73748608 |
157 | mitotic sister chromatid segregation (GO:0000070) | 2.71174093 |
158 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.68559518 |
159 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.67390234 |
160 | mitotic nuclear envelope disassembly (GO:0007077) | 2.66830015 |
161 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.65510824 |
162 | telomere maintenance via recombination (GO:0000722) | 2.60467976 |
163 | viral mRNA export from host cell nucleus (GO:0046784) | 2.59035890 |
164 | regulation of ligase activity (GO:0051340) | 2.58997669 |
165 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.58872315 |
166 | monosaccharide biosynthetic process (GO:0046364) | 2.58152775 |
167 | glycosphingolipid catabolic process (GO:0046479) | 2.57832031 |
168 | regulation of mitotic spindle organization (GO:0060236) | 2.56974024 |
169 | oxidative phosphorylation (GO:0006119) | 2.56527039 |
170 | glucose 6-phosphate metabolic process (GO:0051156) | 2.55053029 |
171 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.54493103 |
172 | glycolytic process (GO:0006096) | 2.53490060 |
173 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.53216501 |
174 | gluconeogenesis (GO:0006094) | 2.52221554 |
175 | ribosomal small subunit biogenesis (GO:0042274) | 2.52070206 |
176 | ribosomal large subunit biogenesis (GO:0042273) | 2.50114442 |
177 | mitotic recombination (GO:0006312) | 2.49490393 |
178 | purine nucleobase biosynthetic process (GO:0009113) | 2.49429650 |
179 | DNA replication initiation (GO:0006270) | 2.48224150 |
180 | heme biosynthetic process (GO:0006783) | 2.48116476 |
181 | regulation of cellular amine metabolic process (GO:0033238) | 2.47381661 |
182 | 4-hydroxyproline metabolic process (GO:0019471) | 2.46796987 |
183 | de novo protein folding (GO:0006458) | 2.41801412 |
184 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.41747580 |
185 | hexose biosynthetic process (GO:0019319) | 2.41412972 |
186 | vesicle coating (GO:0006901) | 2.41079694 |
187 | membrane disassembly (GO:0030397) | 2.39066946 |
188 | nuclear envelope disassembly (GO:0051081) | 2.39066946 |
189 | de novo posttranslational protein folding (GO:0051084) | 2.38516034 |
190 | protein targeting to mitochondrion (GO:0006626) | 2.38510271 |
191 | nucleobase biosynthetic process (GO:0046112) | 2.38462816 |
192 | pyrimidine nucleoside salvage (GO:0043097) | 2.38418494 |
193 | pyrimidine-containing compound salvage (GO:0008655) | 2.38418494 |
194 | biotin metabolic process (GO:0006768) | 2.38143154 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.01806469 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.54364446 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.69027595 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.26243435 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.98589059 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.55021046 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.34604536 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.31824634 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.84047510 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.77568153 |
11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.24712304 |
12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.16742939 |
13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.88188160 |
14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.65706151 |
15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.49374571 |
16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31931177 |
17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.25981088 |
18 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25931201 |
19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.24026048 |
20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.23736026 |
21 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.22092641 |
22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.21951907 |
23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.21466035 |
24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.17021531 |
25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.16978389 |
26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.16932412 |
27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.14926823 |
28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.14643438 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11660080 |
30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.09286607 |
31 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.06094185 |
32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99962182 |
33 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.96999408 |
34 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.95454214 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95295726 |
36 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.92988414 |
37 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.85101785 |
38 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82308221 |
39 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.76446814 |
40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74794139 |
41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.74326134 |
42 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68392683 |
43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.64187669 |
44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59218253 |
45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57681091 |
46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.55685297 |
47 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.53447237 |
48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51609941 |
49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50625809 |
50 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.50514518 |
51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.49938686 |
52 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.48158377 |
53 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46513029 |
54 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.46062428 |
55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.45185378 |
56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41254130 |
57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39918529 |
58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.39177716 |
59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38868669 |
60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37316316 |
61 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.35690385 |
62 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.35516927 |
63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34432582 |
64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32600539 |
65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31852225 |
66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31647935 |
67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30165496 |
68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29831586 |
69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28136462 |
70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28085674 |
71 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27266118 |
72 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26674802 |
73 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25873080 |
74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25517929 |
75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25474594 |
76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24029948 |
77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22867644 |
78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21084325 |
79 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19772397 |
80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18512577 |
81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17096886 |
82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16984222 |
83 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.16294945 |
84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16020496 |
85 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15458598 |
86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15286557 |
87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14989147 |
88 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14571855 |
89 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14099324 |
90 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13675198 |
91 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12948486 |
92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.12921110 |
93 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.12108938 |
94 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12100575 |
95 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11519225 |
96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10742066 |
97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10644200 |
98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.10277482 |
99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08996243 |
100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08298417 |
101 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07895196 |
102 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07818456 |
103 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07597257 |
104 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.06756317 |
105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06488264 |
106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.06375152 |
107 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06284631 |
108 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06034402 |
109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04724823 |
110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04519182 |
111 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04414637 |
112 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04326356 |
113 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04164707 |
114 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03058303 |
115 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.00209464 |
116 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.98771725 |
117 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.97173660 |
118 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.97173660 |
119 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.97173660 |
120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97091305 |
121 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96042368 |
122 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94766280 |
123 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.93922241 |
124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91167973 |
125 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90457283 |
126 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.90106567 |
127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88941506 |
128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87924275 |
129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87745227 |
130 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.87424351 |
131 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.86802584 |
132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84465074 |
133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84465074 |
134 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83492949 |
135 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82886597 |
136 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82055389 |
137 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79939775 |
138 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.79641867 |
139 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79401527 |
140 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.78102305 |
141 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.76777971 |
142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75526869 |
143 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75037864 |
144 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74115093 |
145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72572189 |
146 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.71978254 |
147 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71733545 |
148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71299484 |
149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70892466 |
150 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.70682838 |
151 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70500309 |
152 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68740628 |
153 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68314891 |
154 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67610005 |
155 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.67480467 |
156 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.67256474 |
157 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.66038053 |
158 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65930951 |
159 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.65476524 |
160 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.65452426 |
161 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.64190692 |
162 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64106130 |
163 | GATA1_22025678_ChIP-Seq_K562_Human | 0.63884466 |
164 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.63720662 |
165 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63564300 |
166 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.63116431 |
167 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.63084536 |
168 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62255001 |
169 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.61173362 |
170 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61154214 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 7.66936218 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.84159872 |
3 | MP0003806_abnormal_nucleotide_metabolis | 5.29484064 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.90395413 |
5 | MP0005365_abnormal_bile_salt | 4.55709451 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.39748411 |
7 | MP0005332_abnormal_amino_acid | 3.82231823 |
8 | MP0003195_calcinosis | 3.52339071 |
9 | MP0003693_abnormal_embryo_hatching | 3.40874762 |
10 | MP0004019_abnormal_vitamin_homeostasis | 3.23405486 |
11 | MP0003252_abnormal_bile_duct | 3.13669315 |
12 | MP0009840_abnormal_foam_cell | 3.02448719 |
13 | MP0003111_abnormal_nucleus_morphology | 2.86528250 |
14 | MP0002877_abnormal_melanocyte_morpholog | 2.79394810 |
15 | MP0004957_abnormal_blastocyst_morpholog | 2.76882025 |
16 | MP0010094_abnormal_chromosome_stability | 2.58114187 |
17 | MP0004043_abnormal_pH_regulation | 2.55344458 |
18 | MP0001666_abnormal_nutrient_absorption | 2.42952187 |
19 | MP0003186_abnormal_redox_activity | 2.41792172 |
20 | MP0010329_abnormal_lipoprotein_level | 2.40856368 |
21 | MP0009643_abnormal_urine_homeostasis | 2.36408608 |
22 | MP0008007_abnormal_cellular_replicative | 2.34636311 |
23 | MP0008932_abnormal_embryonic_tissue | 2.34569497 |
24 | MP0003077_abnormal_cell_cycle | 2.17396866 |
25 | MP0004233_abnormal_muscle_weight | 2.04681034 |
26 | MP0008058_abnormal_DNA_repair | 2.04516156 |
27 | MP0010234_abnormal_vibrissa_follicle | 2.00053405 |
28 | MP0008438_abnormal_cutaneous_collagen | 1.95101187 |
29 | MP0005083_abnormal_biliary_tract | 1.94310150 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.93680829 |
31 | MP0000358_abnormal_cell_content/ | 1.92461465 |
32 | MP0002138_abnormal_hepatobiliary_system | 1.87416386 |
33 | MP0005636_abnormal_mineral_homeostasis | 1.82976258 |
34 | MP0003566_abnormal_cell_adhesion | 1.82871450 |
35 | MP0005319_abnormal_enzyme/_coenzyme | 1.78622762 |
36 | MP0003786_premature_aging | 1.77919978 |
37 | MP0002118_abnormal_lipid_homeostasis | 1.77305370 |
38 | MP0005451_abnormal_body_composition | 1.71539327 |
39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.67189652 |
40 | MP0010030_abnormal_orbit_morphology | 1.64644585 |
41 | MP0001764_abnormal_homeostasis | 1.64246694 |
42 | MP0004147_increased_porphyrin_level | 1.63760275 |
43 | MP0000609_abnormal_liver_physiology | 1.63099262 |
44 | MP0003656_abnormal_erythrocyte_physiolo | 1.58485279 |
45 | MP0005058_abnormal_lysosome_morphology | 1.56127500 |
46 | MP0001756_abnormal_urination | 1.53821753 |
47 | MP0001730_embryonic_growth_arrest | 1.51612529 |
48 | MP0004858_abnormal_nervous_system | 1.51575168 |
49 | MP0001849_ear_inflammation | 1.50781725 |
50 | MP0004272_abnormal_basement_membrane | 1.50219135 |
51 | MP0005257_abnormal_intraocular_pressure | 1.46798951 |
52 | MP0002060_abnormal_skin_morphology | 1.42654414 |
53 | MP0010352_gastrointestinal_tract_polyps | 1.40151459 |
54 | MP0002136_abnormal_kidney_physiology | 1.36868499 |
55 | MP0001765_abnormal_ion_homeostasis | 1.34165694 |
56 | MP0003315_abnormal_perineum_morphology | 1.33165454 |
57 | MP0000350_abnormal_cell_proliferation | 1.31391227 |
58 | MP0001216_abnormal_epidermal_layer | 1.24951944 |
59 | MP0002080_prenatal_lethality | 1.24608678 |
60 | MP0006036_abnormal_mitochondrial_physio | 1.23059960 |
61 | MP0000003_abnormal_adipose_tissue | 1.22502058 |
62 | MP0003011_delayed_dark_adaptation | 1.19119205 |
63 | MP0001881_abnormal_mammary_gland | 1.16814669 |
64 | MP0000372_irregular_coat_pigmentation | 1.09645788 |
65 | MP0009780_abnormal_chondrocyte_physiolo | 1.09182991 |
66 | MP0000537_abnormal_urethra_morphology | 1.08363640 |
67 | MP0005408_hypopigmentation | 1.07817938 |
68 | MP0000920_abnormal_myelination | 1.07693065 |
69 | MP0004264_abnormal_extraembryonic_tissu | 1.07507252 |
70 | MP0003123_paternal_imprinting | 1.07302248 |
71 | MP0000858_altered_metastatic_potential | 1.06659120 |
72 | MP0000678_abnormal_parathyroid_gland | 1.06528383 |
73 | MP0003690_abnormal_glial_cell | 1.05581612 |
74 | MP0009764_decreased_sensitivity_to | 1.03850218 |
75 | MP0005384_cellular_phenotype | 1.02877062 |
76 | MP0000598_abnormal_liver_morphology | 0.99640873 |
77 | MP0003950_abnormal_plasma_membrane | 0.99520790 |
78 | MP0001243_abnormal_dermal_layer | 0.99437347 |
79 | MP0000313_abnormal_cell_death | 0.99047199 |
80 | MP0003868_abnormal_feces_composition | 0.97446640 |
81 | MP0002876_abnormal_thyroid_physiology | 0.96954164 |
82 | MP0001697_abnormal_embryo_size | 0.94704414 |
83 | MP0000013_abnormal_adipose_tissue | 0.94320314 |
84 | MP0004185_abnormal_adipocyte_glucose | 0.92545984 |
85 | MP0000490_abnormal_crypts_of | 0.91437576 |
86 | MP0003718_maternal_effect | 0.90987706 |
87 | MP0003329_amyloid_beta_deposits | 0.90755250 |
88 | MP0008469_abnormal_protein_level | 0.90061512 |
89 | MP0000604_amyloidosis | 0.89600343 |
90 | MP0009765_abnormal_xenobiotic_induced | 0.89243150 |
91 | MP0003941_abnormal_skin_development | 0.88904741 |
92 | MP0005376_homeostasis/metabolism_phenot | 0.87584830 |
93 | MP0002019_abnormal_tumor_incidence | 0.87392023 |
94 | MP0000015_abnormal_ear_pigmentation | 0.87274791 |
95 | MP0005380_embryogenesis_phenotype | 0.86161891 |
96 | MP0001672_abnormal_embryogenesis/_devel | 0.86161891 |
97 | MP0005266_abnormal_metabolism | 0.85803982 |
98 | MP0005621_abnormal_cell_physiology | 0.83595747 |
99 | MP0005377_hearing/vestibular/ear_phenot | 0.83350257 |
100 | MP0003878_abnormal_ear_physiology | 0.83350257 |
101 | MP0009763_increased_sensitivity_to | 0.82329238 |
102 | MP0005330_cardiomyopathy | 0.82154423 |
103 | MP0005395_other_phenotype | 0.81719834 |
104 | MP0005084_abnormal_gallbladder_morpholo | 0.81659087 |
105 | MP0006035_abnormal_mitochondrial_morpho | 0.80759980 |
106 | MP0004885_abnormal_endolymph | 0.80412756 |
107 | MP0000627_abnormal_mammary_gland | 0.80182446 |
108 | MP0009642_abnormal_blood_homeostasis | 0.79503418 |
109 | MP0001853_heart_inflammation | 0.78886365 |
110 | MP0001727_abnormal_embryo_implantation | 0.78809209 |
111 | MP0005647_abnormal_sex_gland | 0.78666962 |
112 | MP0009697_abnormal_copulation | 0.77476978 |
113 | MP0010771_integument_phenotype | 0.77305952 |
114 | MP0001661_extended_life_span | 0.77109805 |
115 | MP0003984_embryonic_growth_retardation | 0.76394921 |
116 | MP0000343_altered_response_to | 0.75239682 |
117 | MP0002938_white_spotting | 0.75078142 |
118 | MP0002163_abnormal_gland_morphology | 0.71126307 |
119 | MP0002088_abnormal_embryonic_growth/wei | 0.69733213 |
120 | MP0002269_muscular_atrophy | 0.69032610 |
121 | MP0000467_abnormal_esophagus_morphology | 0.68552824 |
122 | MP0000647_abnormal_sebaceous_gland | 0.68128514 |
123 | MP0005670_abnormal_white_adipose | 0.67908515 |
124 | MP0006082_CNS_inflammation | 0.64158290 |
125 | MP0002168_other_aberrant_phenotype | 0.60768013 |
126 | MP0002796_impaired_skin_barrier | 0.59752209 |
127 | MP0003638_abnormal_response/metabolism_ | 0.56122765 |
128 | MP0008260_abnormal_autophagy | 0.55374638 |
129 | MP0008873_increased_physiological_sensi | 0.54823306 |
130 | MP0002295_abnormal_pulmonary_circulatio | 0.54137860 |
131 | MP0001542_abnormal_bone_strength | 0.52952176 |
132 | MP0005535_abnormal_body_temperature | 0.51250027 |
133 | MP0005666_abnormal_adipose_tissue | 0.50073772 |
134 | MP0005501_abnormal_skin_physiology | 0.48860727 |
135 | MP0005220_abnormal_exocrine_pancreas | 0.48623967 |
136 | MP0002132_abnormal_respiratory_system | 0.48305005 |
137 | MP0001958_emphysema | 0.47546395 |
138 | MP0003705_abnormal_hypodermis_morpholog | 0.47310740 |
139 | MP0004782_abnormal_surfactant_physiolog | 0.44517280 |
140 | MP0008872_abnormal_physiological_respon | 0.43949198 |
141 | MP0000462_abnormal_digestive_system | 0.43354966 |
142 | MP0000230_abnormal_systemic_arterial | 0.43044887 |
143 | MP0002135_abnormal_kidney_morphology | 0.42824345 |
144 | MP0002078_abnormal_glucose_homeostasis | 0.41705808 |
145 | MP0003453_abnormal_keratinocyte_physiol | 0.41440109 |
146 | MP0005023_abnormal_wound_healing | 0.38769990 |
147 | MP0002971_abnormal_brown_adipose | 0.38469793 |
148 | MP0005075_abnormal_melanosome_morpholog | 0.38202548 |
149 | MP0005165_increased_susceptibility_to | 0.38074247 |
150 | MP0003075_altered_response_to | 0.37422175 |
151 | MP0000538_abnormal_urinary_bladder | 0.37367364 |
152 | MP0005464_abnormal_platelet_physiology | 0.36955878 |
153 | MP0002928_abnormal_bile_duct | 0.35428552 |
154 | MP0004381_abnormal_hair_follicle | 0.34389388 |
155 | MP0005334_abnormal_fat_pad | 0.34372421 |
156 | MP0001663_abnormal_digestive_system | 0.34255210 |
157 | MP0001845_abnormal_inflammatory_respons | 0.34130516 |
158 | MP0000477_abnormal_intestine_morphology | 0.32322434 |
159 | MP0004142_abnormal_muscle_tone | 0.32114792 |
160 | MP0005381_digestive/alimentary_phenotyp | 0.31142569 |
161 | MP0003172_abnormal_lysosome_physiology | 0.30787185 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.52447182 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.41385878 |
3 | Hyperglycinuria (HP:0003108) | 4.89681404 |
4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.87672983 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.59807989 |
6 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.55086072 |
7 | Abnormality of glycine metabolism (HP:0010895) | 4.55086072 |
8 | Xanthomatosis (HP:0000991) | 4.41269858 |
9 | Abnormal gallbladder physiology (HP:0012438) | 4.30383938 |
10 | Cholecystitis (HP:0001082) | 4.30383938 |
11 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.12652623 |
12 | Hyperammonemia (HP:0001987) | 4.06700547 |
13 | Gout (HP:0001997) | 4.06102524 |
14 | Hypobetalipoproteinemia (HP:0003563) | 3.90012654 |
15 | Proximal tubulopathy (HP:0000114) | 3.85807859 |
16 | Hyperglycinemia (HP:0002154) | 3.83510766 |
17 | Deep venous thrombosis (HP:0002625) | 3.80453427 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.73822712 |
19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.62060506 |
20 | Generalized aminoaciduria (HP:0002909) | 3.61985969 |
21 | Ketosis (HP:0001946) | 3.59518500 |
22 | Metabolic alkalosis (HP:0200114) | 3.50468347 |
23 | Alkalosis (HP:0001948) | 3.45304228 |
24 | Prolonged partial thromboplastin time (HP:0003645) | 3.41216046 |
25 | Hyperlipoproteinemia (HP:0010980) | 3.39478076 |
26 | Hyperactive renin-angiotensin system (HP:0000841) | 3.39141531 |
27 | Abnormality of purine metabolism (HP:0004352) | 3.36720343 |
28 | Increased circulating renin level (HP:0000848) | 3.34596818 |
29 | Hypokalemic alkalosis (HP:0001949) | 3.29728163 |
30 | Dicarboxylic aciduria (HP:0003215) | 3.23896925 |
31 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.23896925 |
32 | Abnormality of chloride homeostasis (HP:0011422) | 3.22820318 |
33 | Hypomagnesemia (HP:0002917) | 3.21310295 |
34 | Abnormality of methionine metabolism (HP:0010901) | 3.19410745 |
35 | Fat malabsorption (HP:0002630) | 3.17945452 |
36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.16549732 |
37 | Increased purine levels (HP:0004368) | 3.14050133 |
38 | Hyperuricemia (HP:0002149) | 3.14050133 |
39 | Lethargy (HP:0001254) | 3.09511864 |
40 | Short nail (HP:0001799) | 3.05097806 |
41 | Ketoacidosis (HP:0001993) | 3.02293724 |
42 | Vascular calcification (HP:0004934) | 3.01482589 |
43 | Abnormality of urine glucose concentration (HP:0011016) | 3.00826469 |
44 | Glycosuria (HP:0003076) | 3.00826469 |
45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.00691480 |
46 | Hypoglycemic coma (HP:0001325) | 2.98096147 |
47 | Vertebral compression fractures (HP:0002953) | 2.97710907 |
48 | Ileus (HP:0002595) | 2.91606540 |
49 | Abnormality of serum amino acid levels (HP:0003112) | 2.91580560 |
50 | * Metabolic acidosis (HP:0001942) | 2.86442866 |
51 | Delayed CNS myelination (HP:0002188) | 2.85854657 |
52 | Abnormal urine output (HP:0012590) | 2.83703902 |
53 | Hypolipoproteinemia (HP:0010981) | 2.83684417 |
54 | Microvesicular hepatic steatosis (HP:0001414) | 2.82893983 |
55 | Upper limb muscle weakness (HP:0003484) | 2.80043901 |
56 | Hypokinesia (HP:0002375) | 2.79769966 |
57 | Polyuria (HP:0000103) | 2.79386357 |
58 | Premature rupture of membranes (HP:0001788) | 2.76859517 |
59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.76208510 |
60 | Acute necrotizing encephalopathy (HP:0006965) | 2.75080126 |
61 | Abnormality of magnesium homeostasis (HP:0004921) | 2.74943467 |
62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73566896 |
63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73566896 |
64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73566896 |
65 | Type I transferrin isoform profile (HP:0003642) | 2.73322920 |
66 | Rickets (HP:0002748) | 2.72996212 |
67 | Abnormality of proline metabolism (HP:0010907) | 2.68914896 |
68 | Hydroxyprolinuria (HP:0003080) | 2.68914896 |
69 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.67735410 |
70 | Vomiting (HP:0002013) | 2.65053165 |
71 | Cardiovascular calcification (HP:0011915) | 2.64838658 |
72 | Abnormality of renal excretion (HP:0011036) | 2.63859489 |
73 | Joint hemorrhage (HP:0005261) | 2.62333827 |
74 | Hyperbilirubinemia (HP:0002904) | 2.62005510 |
75 | Entropion (HP:0000621) | 2.61561467 |
76 | Reticulocytopenia (HP:0001896) | 2.57518091 |
77 | Malnutrition (HP:0004395) | 2.54053151 |
78 | Rough bone trabeculation (HP:0100670) | 2.53145812 |
79 | Cerebral edema (HP:0002181) | 2.52350375 |
80 | Prolonged neonatal jaundice (HP:0006579) | 2.51739374 |
81 | Steatorrhea (HP:0002570) | 2.51241287 |
82 | Increased serum pyruvate (HP:0003542) | 2.48939192 |
83 | Abnormality of glycolysis (HP:0004366) | 2.48939192 |
84 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.48814586 |
85 | Hepatocellular necrosis (HP:0001404) | 2.48173076 |
86 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.47171644 |
87 | Hepatic necrosis (HP:0002605) | 2.46570310 |
88 | Vacuolated lymphocytes (HP:0001922) | 2.46415445 |
89 | J-shaped sella turcica (HP:0002680) | 2.41919012 |
90 | Irritability (HP:0000737) | 2.41535378 |
91 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41050567 |
92 | Renal salt wasting (HP:0000127) | 2.40309913 |
93 | Progressive muscle weakness (HP:0003323) | 2.39013349 |
94 | Epidermoid cyst (HP:0200040) | 2.38420858 |
95 | Complement deficiency (HP:0004431) | 2.36991389 |
96 | Abnormality of the common coagulation pathway (HP:0010990) | 2.35218876 |
97 | Mitochondrial inheritance (HP:0001427) | 2.35074859 |
98 | Ragged-red muscle fibers (HP:0003200) | 2.34703099 |
99 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33084141 |
100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.32811214 |
101 | Orthostatic hypotension (HP:0001278) | 2.32172683 |
102 | Trismus (HP:0000211) | 2.31258446 |
103 | Cholelithiasis (HP:0001081) | 2.29168155 |
104 | Hypoalphalipoproteinemia (HP:0003233) | 2.29081924 |
105 | Increased CSF lactate (HP:0002490) | 2.27361585 |
106 | Opisthotonus (HP:0002179) | 2.27328197 |
107 | Hand muscle atrophy (HP:0009130) | 2.26517273 |
108 | Abnormality of the umbilical cord (HP:0010881) | 2.26471011 |
109 | Reduced antithrombin III activity (HP:0001976) | 2.25201395 |
110 | Nausea (HP:0002018) | 2.23568616 |
111 | Abnormal protein glycosylation (HP:0012346) | 2.23513760 |
112 | Abnormal glycosylation (HP:0012345) | 2.23513760 |
113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.23513760 |
114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.23513760 |
115 | Abnormality of reticulocytes (HP:0004312) | 2.23205649 |
116 | Upper limb amyotrophy (HP:0009129) | 2.20748861 |
117 | Distal upper limb amyotrophy (HP:0007149) | 2.20748861 |
118 | Hyperaldosteronism (HP:0000859) | 2.18974202 |
119 | Confusion (HP:0001289) | 2.18530643 |
120 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.17204796 |
121 | Methylmalonic aciduria (HP:0012120) | 2.16121491 |
122 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15911780 |
123 | Abnormal gallbladder morphology (HP:0012437) | 2.14963170 |
124 | Spastic paraparesis (HP:0002313) | 2.13553512 |
125 | Abnormal trabecular bone morphology (HP:0100671) | 2.11013857 |
126 | Hyperphosphaturia (HP:0003109) | 2.10918685 |
127 | Hyperthyroidism (HP:0000836) | 2.10287937 |
128 | Exercise intolerance (HP:0003546) | 2.09609232 |
129 | Testicular atrophy (HP:0000029) | 2.08893933 |
130 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.08883090 |
131 | Abnormality of vitamin metabolism (HP:0100508) | 2.08566626 |
132 | Abnormal drinking behavior (HP:0030082) | 2.08014688 |
133 | Polydipsia (HP:0001959) | 2.08014688 |
134 | Reticulocytosis (HP:0001923) | 2.06952386 |
135 | Elevated alkaline phosphatase (HP:0003155) | 2.06065737 |
136 | Abnormality of the anterior horn cell (HP:0006802) | 2.05589435 |
137 | Degeneration of anterior horn cells (HP:0002398) | 2.05589435 |
138 | Renal Fanconi syndrome (HP:0001994) | 2.02439300 |
139 | Abnormality of the tricuspid valve (HP:0001702) | 2.00798656 |
140 | Acute encephalopathy (HP:0006846) | 2.00574676 |
141 | Abnormality of the gallbladder (HP:0005264) | 2.00488529 |
142 | Hepatocellular carcinoma (HP:0001402) | 1.99771604 |
143 | Megaloblastic anemia (HP:0001889) | 1.99706287 |
144 | Secondary amenorrhea (HP:0000869) | 1.99668455 |
145 | Nephrolithiasis (HP:0000787) | 1.99549419 |
146 | Sparse eyelashes (HP:0000653) | 1.99176437 |
147 | Abnormality of renin-angiotensin system (HP:0000847) | 1.98706400 |
148 | Hypercholesterolemia (HP:0003124) | 1.98662622 |
149 | Achilles tendon contracture (HP:0001771) | 1.98183876 |
150 | Abnormality of the Achilles tendon (HP:0005109) | 1.98001201 |
151 | Abnormal tarsal ossification (HP:0008369) | 1.97638523 |
152 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.97212296 |
153 | Hypophosphatemic rickets (HP:0004912) | 1.96668211 |
154 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96339447 |
155 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96339447 |
156 | Abnormality of carpal bone ossification (HP:0006257) | 1.96161093 |
157 | Tetany (HP:0001281) | 1.95667252 |
158 | Widely patent fontanelles and sutures (HP:0004492) | 1.95622350 |
159 | Hypochromic microcytic anemia (HP:0004840) | 1.94951649 |
160 | Hypertensive crisis (HP:0100735) | 1.94889194 |
161 | Nuclear cataract (HP:0100018) | 1.94195905 |
162 | Glucose intolerance (HP:0000833) | 1.93539075 |
163 | Increased hepatocellular lipid droplets (HP:0006565) | 1.93530939 |
164 | Enlarged kidneys (HP:0000105) | 1.93390712 |
165 | Fasciculations (HP:0002380) | 1.92767817 |
166 | Progressive macrocephaly (HP:0004481) | 1.91824354 |
167 | Lactic acidosis (HP:0003128) | 1.87537709 |
168 | Increased serum lactate (HP:0002151) | 1.86441488 |
169 | Lipid accumulation in hepatocytes (HP:0006561) | 1.86334106 |
170 | Increased intramyocellular lipid droplets (HP:0012240) | 1.84705326 |
171 | Dysostosis multiplex (HP:0000943) | 1.82781828 |
172 | Microretrognathia (HP:0000308) | 1.81763825 |
173 | Abnormal hair laboratory examination (HP:0003328) | 1.81402187 |
174 | Seborrheic dermatitis (HP:0001051) | 1.81265806 |
175 | Progressive neurologic deterioration (HP:0002344) | 1.81195801 |
176 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.79840467 |
177 | Single umbilical artery (HP:0001195) | 1.79840467 |
178 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.79840467 |
179 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78662897 |
180 | Cervical subluxation (HP:0003308) | 1.76516742 |
181 | Respiratory failure (HP:0002878) | 1.76163745 |
182 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75460586 |
183 | Poikiloderma (HP:0001029) | 1.73845710 |
184 | Increased muscle lipid content (HP:0009058) | 1.72580684 |
185 | Truncus arteriosus (HP:0001660) | 1.72335455 |
186 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.70360164 |
187 | Hepatosplenomegaly (HP:0001433) | 1.67420638 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OXSR1 | 5.14884071 |
2 | BCKDK | 4.53061075 |
3 | WNK4 | 4.52346278 |
4 | STK39 | 4.48249960 |
5 | VRK2 | 3.69328457 |
6 | PBK | 3.52982366 |
7 | WNK3 | 3.45900437 |
8 | MET | 2.77368662 |
9 | PIK3CG | 2.67577288 |
10 | TESK1 | 2.60081926 |
11 | EPHB1 | 2.46125091 |
12 | MST4 | 2.34884586 |
13 | EPHA2 | 2.30487245 |
14 | SCYL2 | 2.14568510 |
15 | MST1R | 2.11476807 |
16 | SMG1 | 2.08026132 |
17 | ERBB4 | 2.05785104 |
18 | STK38L | 1.87449426 |
19 | IRAK3 | 1.81248350 |
20 | FGFR4 | 1.71803149 |
21 | TRIB3 | 1.60629239 |
22 | ERN1 | 1.59084524 |
23 | LIMK1 | 1.58986802 |
24 | PIM2 | 1.50753302 |
25 | ABL2 | 1.44671569 |
26 | SRPK1 | 1.39609479 |
27 | BRSK1 | 1.33571031 |
28 | CDK8 | 1.30319312 |
29 | PRPF4B | 1.26573807 |
30 | MAP3K12 | 1.25640658 |
31 | NME2 | 1.24660603 |
32 | DAPK1 | 1.22872836 |
33 | CDC7 | 1.20299760 |
34 | TRIM28 | 1.20255586 |
35 | MAP3K11 | 1.19924512 |
36 | PDK2 | 1.18574770 |
37 | PINK1 | 1.18456254 |
38 | BLK | 1.17075792 |
39 | WNK1 | 1.16988703 |
40 | WEE1 | 1.16663551 |
41 | CDK7 | 1.16624540 |
42 | MAPK15 | 1.15577232 |
43 | LMTK2 | 1.11710456 |
44 | TSSK6 | 1.11622616 |
45 | ILK | 1.08112314 |
46 | MAP3K14 | 1.06393831 |
47 | SIK1 | 1.00999823 |
48 | CCNB1 | 0.99247924 |
49 | MAPK11 | 0.98542488 |
50 | PRKG2 | 0.98103701 |
51 | TESK2 | 0.97587573 |
52 | AURKA | 0.97434475 |
53 | MAP2K3 | 0.96772143 |
54 | ICK | 0.96408647 |
55 | AURKB | 0.94050078 |
56 | STK10 | 0.92965673 |
57 | NME1 | 0.90990663 |
58 | VRK1 | 0.88237304 |
59 | PKN2 | 0.88225398 |
60 | BCR | 0.86684427 |
61 | PDK3 | 0.85981829 |
62 | PDK4 | 0.85981829 |
63 | STK16 | 0.83549260 |
64 | CHEK2 | 0.80950294 |
65 | CAMK2G | 0.80939713 |
66 | MAP2K2 | 0.80932297 |
67 | PLK1 | 0.77404628 |
68 | MATK | 0.76738918 |
69 | SGK223 | 0.75973798 |
70 | SGK494 | 0.75973798 |
71 | PKN1 | 0.75687662 |
72 | MAP3K6 | 0.75659189 |
73 | CLK1 | 0.75451343 |
74 | PTK2 | 0.72235025 |
75 | SIK3 | 0.72007835 |
76 | PLK3 | 0.71468408 |
77 | RPS6KB2 | 0.71051953 |
78 | PRKD3 | 0.68439142 |
79 | ATR | 0.68013076 |
80 | GSK3A | 0.66240804 |
81 | MYLK | 0.65018386 |
82 | MUSK | 0.64192125 |
83 | EIF2AK3 | 0.63796215 |
84 | MAP3K3 | 0.63048007 |
85 | TRPM7 | 0.62536663 |
86 | TBK1 | 0.62001794 |
87 | CSF1R | 0.61799835 |
88 | GRK1 | 0.61367349 |
89 | AKT3 | 0.58439150 |
90 | BRSK2 | 0.58369246 |
91 | DAPK3 | 0.57939156 |
92 | NEK1 | 0.57460920 |
93 | BUB1 | 0.56071750 |
94 | GRK6 | 0.55573524 |
95 | EIF2AK1 | 0.55148472 |
96 | RPS6KA4 | 0.54948766 |
97 | CSNK1G3 | 0.54028758 |
98 | CHEK1 | 0.53563064 |
99 | EPHB2 | 0.53412977 |
100 | DYRK1B | 0.52566903 |
101 | BMX | 0.52405960 |
102 | BRAF | 0.51822054 |
103 | ARAF | 0.51167212 |
104 | TTK | 0.50893519 |
105 | PAK2 | 0.50185205 |
106 | FLT3 | 0.49122812 |
107 | CSK | 0.48565705 |
108 | AKT2 | 0.47631520 |
109 | MAPKAPK3 | 0.46794936 |
110 | PIM1 | 0.46791342 |
111 | CSNK1G1 | 0.46741215 |
112 | MAP2K6 | 0.45600929 |
113 | CSNK2A2 | 0.45175101 |
114 | CDK14 | 0.44635004 |
115 | PRKCI | 0.44467561 |
116 | IKBKB | 0.42990074 |
117 | INSRR | 0.41814630 |
118 | MAPKAPK5 | 0.41573462 |
119 | IRAK2 | 0.41204430 |
120 | NEK2 | 0.41020800 |
121 | PAK4 | 0.39426478 |
122 | CAMK2B | 0.39145196 |
123 | MAPK7 | 0.39117531 |
124 | DDR2 | 0.38694928 |
125 | PTK6 | 0.38536568 |
126 | RAF1 | 0.38222548 |
127 | CSNK2A1 | 0.38067006 |
128 | PRKCQ | 0.38030183 |
129 | ERBB2 | 0.37726996 |
130 | PDGFRA | 0.37506784 |
131 | PDPK1 | 0.37462386 |
132 | CDK18 | 0.35468741 |
133 | PLK4 | 0.35358324 |
134 | CSNK1A1L | 0.35115782 |
135 | TYK2 | 0.34946997 |
136 | PRKCD | 0.34373081 |
137 | CDK9 | 0.34231315 |
138 | CDK11A | 0.32630067 |
139 | PRKACG | 0.32276470 |
140 | LRRK2 | 0.31468769 |
141 | CAMK2D | 0.31372462 |
142 | MAP3K8 | 0.31319413 |
143 | FGFR2 | 0.29737391 |
144 | PRKAA2 | 0.29070631 |
145 | FGR | 0.28925350 |
146 | PRKAA1 | 0.28663129 |
147 | PAK1 | 0.28341735 |
148 | FRK | 0.27246764 |
149 | STK4 | 0.26801674 |
150 | IRAK1 | 0.26641314 |
151 | PRKCZ | 0.24769745 |
152 | TAOK2 | 0.24111457 |
153 | KDR | 0.23874504 |
154 | PIK3CA | 0.23289684 |
155 | NEK9 | 0.23246105 |
156 | NTRK1 | 0.23038768 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.10024113 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01027250 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.00505625 |
4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75319992 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.71786007 |
6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.69433683 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.52838073 |
8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.49035686 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.47049515 |
10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.46912554 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33648833 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31620585 |
13 | Base excision repair_Homo sapiens_hsa03410 | 2.28963030 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27875374 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.27380051 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.26977631 |
17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26793141 |
18 | Mismatch repair_Homo sapiens_hsa03430 | 2.24658204 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.21522026 |
20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.17335453 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03216230 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01957136 |
23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.93399065 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92029799 |
25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.84967898 |
26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.82332065 |
27 | Ribosome_Homo sapiens_hsa03010 | 1.77536342 |
28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76024769 |
29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75925240 |
30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75489891 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74852183 |
32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.72778511 |
33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70503271 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69999674 |
35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66073551 |
36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.61662517 |
37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.60788109 |
38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57901136 |
39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.56492468 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53578165 |
41 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.53236354 |
42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.52583077 |
43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.47589361 |
44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47025621 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43892727 |
46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41773785 |
47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39960855 |
48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37845899 |
49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37402695 |
50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.37108376 |
51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36619358 |
52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.36465723 |
53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36161584 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.35852666 |
55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33717909 |
56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31876359 |
57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29662780 |
58 | Bile secretion_Homo sapiens_hsa04976 | 1.26152414 |
59 | RNA polymerase_Homo sapiens_hsa03020 | 1.25043585 |
60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.22868406 |
61 | Spliceosome_Homo sapiens_hsa03040 | 1.19520110 |
62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19517267 |
63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19229114 |
64 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19189823 |
65 | RNA transport_Homo sapiens_hsa03013 | 1.18263796 |
66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17708826 |
67 | Homologous recombination_Homo sapiens_hsa03440 | 1.16732917 |
68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09071158 |
69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04755026 |
70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99680268 |
71 | Cell cycle_Homo sapiens_hsa04110 | 0.97779342 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96528046 |
73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95130322 |
74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94277743 |
75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92935336 |
76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92575162 |
77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85681533 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82933069 |
79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81775377 |
80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80599939 |
81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76591027 |
82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76342694 |
83 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.74927010 |
84 | ABC transporters_Homo sapiens_hsa02010 | 0.74533610 |
85 | Purine metabolism_Homo sapiens_hsa00230 | 0.72668846 |
86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70931200 |
87 | Shigellosis_Homo sapiens_hsa05131 | 0.67645920 |
88 | Mineral absorption_Homo sapiens_hsa04978 | 0.65541100 |
89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63729103 |
90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61996960 |
91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60694138 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59370913 |
93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59220983 |
94 | Lysine degradation_Homo sapiens_hsa00310 | 0.55948676 |
95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55747784 |
96 | Bladder cancer_Homo sapiens_hsa05219 | 0.55385374 |
97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50211032 |
98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46194378 |
99 | Proteasome_Homo sapiens_hsa03050 | 0.41356901 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39988424 |
101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38148123 |
102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37524318 |
103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36163337 |
104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35948120 |
105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33960259 |
106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33916098 |
107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32528000 |
108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29594071 |
109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29509454 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.28457133 |
111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.28023077 |
112 | Lysosome_Homo sapiens_hsa04142 | 0.26587276 |
113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26067422 |
114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24759148 |
115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20913918 |
116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20884511 |
117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19275281 |
118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18000847 |
119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16929634 |
120 | RNA degradation_Homo sapiens_hsa03018 | 0.16685046 |
121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.12812641 |
122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09955917 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07670603 |
124 | Alzheimers disease_Homo sapiens_hsa05010 | 0.06714644 |
125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06510732 |
126 | Huntingtons disease_Homo sapiens_hsa05016 | 0.02303921 |
127 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.02047326 |
128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.01046802 |
129 | Protein export_Homo sapiens_hsa03060 | -0.0667974 |
130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0611322 |
131 | Hepatitis C_Homo sapiens_hsa05160 | -0.0605816 |
132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0417403 |
133 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0195270 |